+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
UCB (Union chimique belge) - logo

UCB is a global biopharmaceutical company that focuses on neurology and immunology. The company’s core products are Cimzia, Vimpat, Neupro, Keppra and Briviact, and they are also preparing the launch of a potential medicine to help patients with osteoporosis. It offers products for the treatment of central nervous system disorders, allergy and respiratory diseases, and immune and inflammatory disorders. UCB employs over 7,000 people and is based in Brussels, Belgium.

Crohn's Disease Therapeutics Market - Global Forecast 2025-2032 - Product Thumbnail Image

Crohn's Disease Therapeutics Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 186 Pages
  • Global
From
Anti-Rheumatics Market - Global Forecast 2025-2032 - Product Thumbnail Image

Anti-Rheumatics Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 187 Pages
  • Global
From
Collagen Vascular Diseases Market - Global Forecast 2025-2032 - Product Thumbnail Image

Collagen Vascular Diseases Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 199 Pages
  • Global
From
TNF Inhibitors Market - Global Forecast 2025-2032 - Product Thumbnail Image

TNF Inhibitors Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 192 Pages
  • Global
From
From
From
From
Crohn's Disease (CD) Treatment Market Report 2025 - Product Thumbnail Image

Crohn's Disease (CD) Treatment Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Epidural Abscess Treatment Market Report 2025 - Product Thumbnail Image

Epidural Abscess Treatment Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
From
Autoimmune Treatment Market Report 2025 - Product Thumbnail Image

Autoimmune Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
Loading Indicator